Resistance to chemotherapy mediated by TrkB in neuroblastomas.

Ruth Ho(Children's Hospital of Philadelphia), Garrett M. Brodeur(Children's Hospital of Philadelphia), Naohiko Ikegaki(University of Illinois Chicago), Angelika Eggert(MSB Medical School Berlin), Tomoro Hishiki(California University of Pennsylvania), Patricia Foster(California University of Pennsylvania), Jane E. Minturn(St Nicholas Hospital), Anna Marie Camoratto(Avalon Pharma (United States)), Audrey E. Evans(Purdue University West Lafayette)
PubMed
November 15, 2002
Cited by 232

Related Papers

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
|Journal of Clinical Oncology|1993|2.3k
A proposed staging for children with neuroblastoma.Children's cancer study group A
|Cancer|1971|953
Treatment of Wilms' tumor. Results of the third national Wilms' tumor study
|Cancer|1989|685
Telomerase activation by genomic rearrangements in high-risk neuroblastoma
|Nature|2015|608
International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.
|Journal of Clinical Oncology|1988|608